| Ident. | Authors (with country if any) | Title |
|---|
| 000055 (2012) |
Oleg V. Pyankov [Australie, Russie] ; Olga G. Pyankova [Australie, Russie] ; Igor E. Agranovski [Australie] | Inactivation of airborne influenza virus in the ambient air |
| 000072 (2011) |
Thi Thanh Hanh Nguyen [Corée du Sud] ; Hwa-Ja Ryu [Corée du Sud] ; Se-Hoon Lee [Corée du Sud] ; Soonwook Hwang [Corée du Sud] ; Vincent Breton [France] ; JOON HAENG RHEE [Corée du Sud] ; Doman Kim [Corée du Sud] | Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation |
| 000084 (2011) |
Taesub Lim [Corée du Sud] ; Jinkyun Cho [Corée du Sud] ; BYUNGSEON SEAN KIM [Corée du Sud] | Predictions and measurements of the stack effect on indoor airborne virus transmission in a high-rise hospital building |
| 000127 (2010) |
R. Ramajayam [Taïwan] ; Kian-Pin Tan [Taïwan] ; Hun-Ge Liu [Taïwan] ; Po-Huang Liang [Taïwan] | Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease |
| 000129 (2010) |
R. Ramajayam [Taïwan] ; Kian-Pin Tan [Taïwan] ; Hun-Ge Liu [Taïwan] ; Po-Huang Liang [Taïwan] | Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors |
| 000132 (2010) |
YOUNG BAE RYU [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; YOUNG MIN KIM [Corée du Sud] ; Ju-Yeon Lee [Corée du Sud] ; WOO DUCK SEO [Corée du Sud] ; JONG SUN CHANG [Corée du Sud] ; KI HUN PARK [Corée du Sud] ; Mun-Chual Rho [Corée du Sud] ; WOO SONG LEE [Corée du Sud] | SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii |
| 000159 (2010) |
YOUNG BAE RYU [Corée du Sud] ; HYUNG JAE JEONG [Corée du Sud] ; JANG HOON KIM [Corée du Sud] ; YOUNG MIN KIM [Corée du Sud] ; Ji-Young Park [Corée du Sud] ; Doman Kim [Corée du Sud] ; Thi Thanh Hanh Naguyen [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; JONG SUN CHANG [Corée du Sud] ; KI HUN PARK [Corée du Sud] ; Mun-Chual Rho [Corée du Sud] ; WOO SONG LEE [Corée du Sud] | Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition |
| 000162 (2010) |
Stefan Mebs [Allemagne] ; Anja Lüth [Allemagne] ; Peter Luger [Allemagne] | A simple procedure for the derivation of electron density based surfaces of drug-receptor complexes from a combination of X-ray data and theoretical calculations |
| 000183 (2009) |
Arun K. Ghosh [États-Unis] ; Jun Takayama [États-Unis] ; Yoann Aubin [États-Unis] ; Kiira Ratia [États-Unis] ; Rima Chaudhuri [États-Unis] ; Yahira Baez [États-Unis] ; Katrina Sleeman [États-Unis] ; Melissa Coughlin [États-Unis] ; Daniel B. Nichols [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Susan C. Bakery [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis] | Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease |
| 000198 (2009) |
Andrea Spallarossa [Italie] ; Sara Cesarini [Italie] ; Angelo Ranise [Italie] ; Silvia Schenone [Italie] ; Olga Bruno [Italie] ; Alberto Borassi [Italie] ; Paolo La Colla [Italie] ; Margherita Pezzullo [Italie] ; Giuseppina Sanna [Italie] ; Gabriella Collu [Italie] ; Barbara Secci [Italie] ; Roberta Loddo [Italie] | Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors |
| 000200 (2009) |
Andrea Spallarossa [Italie] ; Sara Cesarini [Italie] ; Angelo Ranise [Italie] ; Olga Bruno [Italie] ; Silvia Schenone [Italie] ; Paolo La Colla [Italie] ; Gabriella Collu [Italie] ; Giuseppina Sanna [Italie] ; Barbara Secci [Italie] ; Roberta Loddo [Italie] | Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors |
| 000201 (2009) |
Thomas Regnier [Japon] ; Diganta Sarma [Japon] ; Koushi Hidaka [Japon] ; Usman Bacha [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon] ; Yoshiaki Kiso [Japon] | New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors |
| 000205 (2009) |
Ji-Lung Hsieh [Taïwan] ; Chung-Yuan Huang [Taïwan] ; Chuen-Tsai Sun [Taïwan] ; Yu-Shiuan Tsai [Taïwan] ; Gloria Yi-Ming Kao [Taïwan] | Learning to build network-oriented epidemic simulation models in epidemiology education : Modelling and simulation education |
| 000206 (2009) |
Chaewoon Lee [Corée du Sud] ; JIN MOO LEE [Corée du Sud] ; Na-Ra Lee [Corée du Sud] ; Dong-Eun Kim [Corée du Sud] ; Yong-Joo Jeong [Corée du Sud] ; Youhoon Chong [Corée du Sud] | Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives |
| 000237 (2008) |
Sara Cesarini [Italie] ; Andrea Spallarossa [Italie] ; Angelo Ranise [Italie] ; Olga Bruno [Italie] ; Paolo La Colla [Italie] ; Barbara Secci [Italie] ; Gabriella Collu [Italie] ; Roberta Loddo [Italie] | Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2. Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate |
| 000238 (2008) |
Sara Cesarini [Italie] ; Andrea Spallarossa [Italie] ; Angelo Ranise [Italie] ; Paola Fossa [Italie] ; Paolo La Colla [Italie] ; Giuseppina Sanna [Italie] ; Gabriella Collu [Italie] ; Roberta Loddo [Italie] | Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates |
| 000246 (2008) |
Prasenjit Mukherjee [États-Unis] ; Prashant Desai [États-Unis] ; Larry Ross [États-Unis] ; E. Lucile White [États-Unis] ; Mitchell A. Avery [États-Unis] | Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits |
| 000267 (2008) |
CHUNYING NIU [Canada] ; JIANG YIN [Canada] ; JIANMIN ZHANG [Canada] ; John C. Vederas [Canada] ; Michael N. G. James [Canada] | Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro |
| 000280 (2008) |
Carly Huitema [Canada] ; JIANMIN ZHANG [Canada] ; JIANG YIN [Canada] ; Michael N. G. James [Canada] ; John C. Vederas [Canada] ; Lindsay D. Eltis [Canada] | Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase : Evaluation of mode of action |
| 000290 (2008) |
Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis] | Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease |
| 000291 (2008) |
Arun K. Ghosh [États-Unis] ; GANGLI GONG [États-Unis] ; Valerie Grum-Tokars [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Susan C. Baker [États-Unis] ; Melissa Coughlin [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Katrina Sleeman [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis] | Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors |
